Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TTC26 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | GRTP1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | TNFRSF25 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
mRNA | RNF181 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
mRNA | SLC25A16 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | AC104389.1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
mRNA | ALPK1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | KAT6A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | DGKK | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | CA1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |